Charles River Laboratories | CRL - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Agilent USD 29M 4M 2026-06
Align Technology USD 9.96M 3.02M 2026-06
Bio-Rad Laboratories USD 12.1M 200K 2026-06
Bruker USD 17.8M 9.7M 2026-06
Cardinal Health USD 73M 6M 2026-09
Charles River Laboratories USD 28.52M 1.82M 2026-09
Cigna USD 157.08B 3.82B 2026-06
Concord Medical Services Hldg CNY 84.37M 32.34M 2023-06
CVS Health USD 747M 10M 2026-09
Danaher USD 135M 28M 2026-09
Dentsply International USD 22M 2M 2026-06
Elevance Health USD 358M 6M 2026-09
Humana USD 197M 4M 2026-06
Illumina USD 24M 0 2026-09
Incyte USD 605K 23K 2026-09
Intrexon USD 2K 5K 2024-06
IQVIA Holdings USD 203M 6M 2026-09
Laboratory Of America USD 59.1M 2M 2026-09
Lakefront Biotherapeutics EUR 1.72M 940K 2025-09
Lonza CHF 84M 14M 2025-06
McKesson USD 105M 28M 2026-09
Merck EUR 137M 33M 2026-06
Mettler Toledo International USD 17.25M 239K 2026-06
Novartis USD 468M 6M 2026-09
Pfizer USD 662M 5M 2026-09
Quest Diagnostics USD 61M 8M 2026-09
Revvity USD 20.81M 2.18M 2026-09
Thermo Fisher Scientific USD 417M 63M 2026-09
United Therapeutics USD 2.9M 0 2026-09
UnitedHealth USD 963M 1000K 2026-09
Veradigm USD 1.25M 641K 2022-09
Waters USD 53M 2M 2026-09
West Pharmaceutical Services USD 3.8M 1.2M 2026-09